+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical IVD Reagents Market - Global Forecast 2026-2032- Product Image
Clinical IVD Reagents Market - Global Forecast 2026-2032- Product Image
Sale

Clinical IVD Reagents Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6151169
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical IVD Reagents Market is projected to reach USD 64.04 Billion in 2026. It is expected to continue growing at a CAGR of 7.41%, reaching USD 97.98 Billion by 2032.

Clinical IVD Reagents: Executive Overview

Clinical in vitro diagnostic (IVD) reagents are the chemical, biological, and molecular components used with diagnostic instruments and workflows to detect, identify, or quantify analytes in patient specimens. They support applications including clinical chemistry, immunoassay, hematology, coagulation, microbiology, and molecular diagnostics. Demand is shaped by routine testing, chronic disease management, infectious-disease surveillance, emergency care, laboratory automation, and the need for faster, more reliable clinical decisions.

Laboratory Transformation Is Reshaping Reagent Requirements

Clinical laboratories are shifting toward automation, connected workflows, multiplex testing, and decentralized or near-patient diagnostics. These changes increase the importance of reagent stability, instrument compatibility, lot-to-lot consistency, sample-to-answer integration, and streamlined quality control. Consolidation of testing activity, workforce constraints, supply-chain disruptions, and tighter regulatory expectations are also encouraging laboratories to standardize platforms and improve utilization of consumables.

The landscape is simultaneously becoming more decentralized and more data-driven. Central laboratories continue to emphasize throughput and operational efficiency, while hospitals, physician offices, and other care settings seek rapid results with manageable complexity. Reagent suppliers and laboratory stakeholders therefore need to balance analytical performance with storage requirements, ease of use, workflow integration, and lifecycle support.

Artificial Intelligence Strengthens Reagent-Enabled Diagnostic Workflows

Artificial intelligence is influencing clinical IVD through instrument control, image interpretation, result validation, anomaly detection, quality monitoring, and laboratory scheduling. AI can help identify unusual patterns, prioritize review, and reduce repetitive manual tasks when deployed within validated clinical workflows. Its practical value depends on high-quality input data, transparent performance evaluation, appropriate human oversight, and compatibility with laboratory information systems.

For reagent development and operations, AI can support formulation screening, stability analysis, demand planning, maintenance prediction, and detection of process variation. It does not remove the need for analytical validation or regulatory compliance. Instead, its cumulative impact is to make reagent performance, metadata, calibration, and traceability more strategically important across the diagnostic value chain.

Regional Patterns: Diverse Regulation, Infrastructure, and Testing Priorities

North America combines advanced laboratory infrastructure, high adoption of automation, and strong expectations for analytical validation, cybersecurity, and regulatory documentation. Europe emphasizes harmonized regulatory processes, quality systems, sustainability, and cross-border interoperability, while national procurement structures continue to influence adoption. Asia-Pacific spans highly sophisticated laboratory networks and rapidly expanding access, creating varied requirements for automation, affordability, localization, and technical support.

Latin America is characterized by uneven laboratory capacity, public-private system differences, and demand for dependable reagents that can function across diverse operating conditions. The Middle East is investing in healthcare modernization, specialized testing, and centralized laboratory capabilities, with procurement and localization considerations remaining important. Africa presents a broad range of laboratory maturity levels; priorities include reliable supply, workforce training, quality assurance, disease surveillance, and solutions suited to infrastructure and environmental constraints.

Group Insights: Economic and Security Blocs Shape Access and Standards

ASEAN markets reflect varied regulatory systems, healthcare resources, and laboratory capabilities, making adaptable distribution, training, and regional quality practices valuable. BRICS members encompass major diagnostic ecosystems with differing industrial policies, procurement models, and local manufacturing priorities. The European Union places strong emphasis on regulatory conformity, laboratory quality, data governance, and coordinated health-system requirements.

G7 countries generally combine mature laboratory networks with sophisticated clinical validation, automation, and research capabilities. GCC countries are strengthening centralized testing, healthcare infrastructure, and specialized services while balancing imported technology with localization goals. NATO members operate across diverse health systems, but resilience, continuity of supply, emergency preparedness, and secure digital infrastructure are increasingly relevant to diagnostic reagent planning.

Country Insights: Distinct National Priorities Across Major Diagnostic Systems

Australia emphasizes quality assurance, geographically distributed care, and reliable supply for both centralized and remote testing. Brazil combines substantial public-sector demand with regional disparities and growing interest in domestic capability. Canada prioritizes quality, accessibility across large geographies, and integration between laboratory services and healthcare networks. China is advancing laboratory modernization, automation, domestic manufacturing, and broad diagnostic access. France and Germany maintain strong hospital and laboratory infrastructures, with close attention to regulatory compliance, procurement efficiency, and quality systems.

India presents diverse laboratory settings, high testing needs, and strong interest in affordability, decentralization, and local production. Italy and Spain are influenced by public procurement, hospital-network organization, and European regulatory requirements. Japan emphasizes precision, reliability, aging-population care, and advanced automation. Mexico is balancing expanding diagnostic access with infrastructure and supply-chain variability. Russia’s diagnostic environment is shaped by domestic supply considerations, healthcare resilience, and regulatory requirements.

South Korea combines advanced technology adoption with strong laboratory capabilities and manufacturing expertise. The United Kingdom emphasizes quality, clinical utility, procurement discipline, and post-transition regulatory clarity. The United States has extensive laboratory automation and innovation, with demanding expectations for validation, compliance, interoperability, and continuity of supply.

Actions for Leaders: Build Resilient, Validated, and Interoperable Reagent Portfolios

Industry leaders should align product development with clearly defined clinical workflows rather than treating reagents as standalone consumables. Priorities include robust analytical validation, transparent performance claims, stable formulations, simplified handling, and compatibility with automated and decentralized platforms. Dual sourcing of critical inputs, regional inventory planning, strong supplier qualification, and contingency testing can improve resilience.

Leaders should also invest in interoperable data structures, cybersecurity, and controlled AI deployment. Partnerships with laboratories and health systems can reveal workflow bottlenecks and support evidence generation. Regional strategies should account for local regulation, infrastructure, workforce capability, reimbursement, procurement, storage conditions, and training needs. Continuous post-market surveillance and structured customer feedback are essential for maintaining trust and identifying performance issues early.

Research Methodology: Structured Review of Clinical IVD Reagent Dynamics

This executive summary is based on a structured assessment of clinical IVD reagent applications, laboratory workflows, technology adoption, regulatory considerations, healthcare-system characteristics, and regional operating conditions. The analysis distinguishes reagent-related factors from instrument, software, service, and clinical decision-making components.

Insights were organized across the required regions, economic and security groups, and countries, with emphasis on observable industry drivers such as automation, decentralization, chronic disease management, infectious-disease testing, supply-chain resilience, quality systems, and AI-enabled workflow support. Claims are presented qualitatively and avoid market estimates, market shares, forecasts, and unsupported company-specific assertions.

Conclusion: Performance, Resilience, and Clinical Integration Define Progress

Clinical IVD reagents remain foundational to diagnostic quality because they directly influence analytical accuracy, workflow reliability, and the reproducibility of patient results. The sector is being reshaped by automation, decentralized care, regulatory scrutiny, supply-chain priorities, and AI-supported laboratory operations.

The strongest strategic position will come from combining validated performance with practical usability, secure interoperability, resilient sourcing, and regionally appropriate implementation. Organizations that connect reagent innovation to laboratory needs, clinical evidence, and quality management will be better prepared to support dependable diagnosis across diverse healthcare environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Clinical IVD Reagents Market, by Product Type
7.1. Introduction
7.2. Immunoassay Reagents
7.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Reagents
7.2.2. Chemiluminescent Immunoassay (CLIA) Reagents
7.2.3. Fluorescent Immunoassay Reagents
7.2.4. Lateral Flow Immunoassay Reagents
7.2.5. Radioimmunoassay (RIA) Reagents
7.3. Clinical Chemistry Reagents
7.3.1. Enzymatic Assays
7.3.2. Substrate Reagents
7.3.3. Electrolyte Reagents
7.3.4. Metabolite Reagents
7.4. Molecular Diagnostics Reagents
7.4.1. PCR Reagents
7.4.1.1. Real-Time PCR Reagents
7.4.1.2. Digital PCR Reagents
7.4.1.3. Conventional PCR Reagents
7.4.2. Next-Generation Sequencing Reagents
7.4.2.1. Library Preparation Kits
7.4.2.2. Sequencing Kits
7.4.2.3. Target Enrichment Kits
7.4.3. Isothermal Amplification Reagents
7.5. Hematology Reagents
7.5.1. Cell Staining Reagents
7.5.2. Diluent And Lyse Reagents
7.5.3. Hemoglobin Reagents
7.6. Coagulation Reagents
7.6.1. Prothrombin Time (PT/INR) Reagents
7.6.2. Activated Partial Thromboplastin Time (APTT) Reagents
7.6.3. Fibrinogen Reagents
7.7. Microbiology Reagents
7.7.1. Culture Media
7.7.2. Rapid Antigen Tests
7.7.3. Antibody Detection Kits
7.7.4. Molecular Microbiology Reagents
7.7.5. MALDI-TOF Reagents
7.8. Toxicology Reagents
7.9. Urinalysis Reagents
7.10. Histology And Cytology Reagents
7.11. Flow Cytometry Reagents
7.12. Point Of Care Reagents
8. Clinical IVD Reagents Market, by Technology Platform
8.1. Introduction
8.2. Enzyme-Linked Immunosorbent Assay (ELISA)
8.3. Chemiluminescence Immunoassay (CLIA)
8.4. Lateral Flow Immunoassay
8.5. Polymerase Chain Reaction (PCR)
8.6. Next-Generation Sequencing (NGS)
8.7. Mass Spectrometry
8.8. Flow Cytometry
8.9. Immunoturbidimetry
8.10. Microarray
8.11. MALDI-TOF
9. Clinical IVD Reagents Market, by Sample Type
9.1. Introduction
9.2. Whole Blood
9.3. Serum
9.4. Plasma
9.5. Urine
9.6. Saliva
9.7. Swab Samples
9.7.1. Nasopharyngeal Swab
9.7.2. Oropharyngeal Swab
9.8. Cerebrospinal Fluid
9.9. Tissue Biopsy / FFPE
9.10. Stool
9.11. Dried Blood Spots
10. Clinical IVD Reagents Market, by Application Area
10.1. Introduction
10.2. Infectious Disease
10.2.1. Viral Infectious Disease
10.2.2. Bacterial Infectious Disease
10.2.3. Parasitic Infectious Disease
10.2.4. Fungal Infectious Disease
10.3. Oncology
10.3.1. Tumor Markers
10.3.2. Companion Diagnostics
10.4. Cardiology
10.5. Diabetes
10.6. Autoimmune Disease
10.7. Endocrinology
10.8. Renal Function
10.9. Hepatic Function
10.10. Prenatal And Neonatal Screening
10.11. Transplantation
10.12. Toxicology
10.13. Pharmacogenomics
11. Clinical IVD Reagents Market, by End User
11.1. Introduction
11.2. Hospital Laboratories
11.3. Reference Laboratories
11.4. Point Of Care Settings
11.4.1. Physician Office
11.4.2. Emergency Department
11.4.3. Ambulatory Care
11.4.4. Home Use
11.5. Research Laboratories
11.6. Blood Banks
11.7. Diagnostic Manufacturers (OEM)
12. Clinical IVD Reagents Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Clinical IVD Reagents Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Clinical IVD Reagents Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Agilent Technologies, Inc.
16.3. ARKRAY, Inc.
16.4. Becton, Dickinson and Company
16.5. Bio-Rad Laboratories, Inc.
16.6. bioMérieux S.A.
16.7. Cepheid AB
16.8. Danaher Corporation
16.9. DiaSorin S.p.A.
16.10. F. Hoffmann-La Roche Ltd
16.11. Grifols, S.A.
16.12. Hologic, Inc.
16.13. Illumina, Inc.
16.14. InTec Products, Inc.
16.15. Luminex Corporation
16.16. Merck KGaA
16.17. Mindray Medical International Limited
16.18. OraSure Technologies, Inc.
16.19. PerkinElmer, Inc.
16.20. QIAGEN N.V.
16.21. Quest Diagnostics Incorporated
16.22. QuidelOrtho Corporation
16.23. Siemens Healthineers AG
16.24. Sysmex Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Clinical IVD Reagents Market, Years Considered for the Study
FIGURE 2. Global Clinical IVD Reagents Market, Research Design
FIGURE 3. Global Clinical IVD Reagents Market, Research Framework
FIGURE 4. Global Clinical IVD Reagents Market, Data Triangulation
FIGURE 5. Global Clinical IVD Reagents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Clinical IVD Reagents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Clinical IVD Reagents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Clinical IVD Reagents Market Size, by Technology Platform, 2025 vs 2032 (%)
FIGURE 9. Global Clinical IVD Reagents Market Size, by Technology Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Clinical IVD Reagents Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Clinical IVD Reagents Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Clinical IVD Reagents Market Size, by Application Area, 2025 vs 2032 (%)
FIGURE 13. Global Clinical IVD Reagents Market Size, by Application Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Clinical IVD Reagents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Clinical IVD Reagents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Clinical IVD Reagents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Clinical IVD Reagents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Clinical IVD Reagents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Clinical IVD Reagents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Clinical IVD Reagents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Clinical IVD Reagents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Clinical IVD Reagents Market Segmentation & Coverage
TABLE 2. Global Clinical IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Clinical IVD Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Immunoassay Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Immunoassay Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Immunoassay Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Chemiluminescent Immunoassay (CLIA) Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Chemiluminescent Immunoassay (CLIA) Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Chemiluminescent Immunoassay (CLIA) Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Fluorescent Immunoassay Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Fluorescent Immunoassay Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Fluorescent Immunoassay Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Lateral Flow Immunoassay Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Lateral Flow Immunoassay Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Lateral Flow Immunoassay Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Radioimmunoassay (RIA) Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Radioimmunoassay (RIA) Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Radioimmunoassay (RIA) Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Clinical Chemistry Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Clinical Chemistry Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Clinical Chemistry Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Enzymatic Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Enzymatic Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Enzymatic Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Substrate Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Substrate Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Substrate Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Electrolyte Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Electrolyte Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Electrolyte Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Metabolite Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Metabolite Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Metabolite Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Molecular Diagnostics Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Molecular Diagnostics Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Molecular Diagnostics Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global PCR Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global PCR Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global PCR Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Real-Time PCR Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Real-Time PCR Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Real-Time PCR Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Digital PCR Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Digital PCR Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Digital PCR Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Conventional PCR Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Conventional PCR Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Conventional PCR Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Next-Generation Sequencing Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Next-Generation Sequencing Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Next-Generation Sequencing Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Library Preparation Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Library Preparation Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Library Preparation Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Sequencing Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Sequencing Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Sequencing Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Target Enrichment Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Target Enrichment Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Target Enrichment Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Isothermal Amplification Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Isothermal Amplification Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Isothermal Amplification Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hematology Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hematology Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hematology Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Cell Staining Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Cell Staining Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Cell Staining Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Diluent And Lyse Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Diluent And Lyse Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Diluent And Lyse Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Hemoglobin Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hemoglobin Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hemoglobin Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Coagulation Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Coagulation Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Coagulation Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Prothrombin Time (PT/INR) Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Prothrombin Time (PT/INR) Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Prothrombin Time (PT/INR) Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Activated Partial Thromboplastin Time (APTT) Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Activated Partial Thromboplastin Time (APTT) Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Activated Partial Thromboplastin Time (APTT) Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Fibrinogen Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Fibrinogen Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Fibrinogen Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Microbiology Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Microbiology Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Microbiology Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Culture Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Culture Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Culture Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Rapid Antigen Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Rapid Antigen Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Rapid Antigen Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Antibody Detection Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Antibody Detection Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Antibody Detection Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Molecular Microbiology Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Molecular Microbiology Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Molecular Microbiology Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global MALDI-TOF Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global MALDI-TOF Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global MALDI-TOF Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Toxicology Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Toxicology Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Toxicology Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Urinalysis Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Urinalysis Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Urinalysis Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Histology And Cytology Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Histology And Cytology Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Histology And Cytology Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Flow Cytometry Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Flow Cytometry Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Flow Cytometry Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Point Of Care Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Point Of Care Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Point Of Care Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Clinical IVD Reagents Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 125. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Chemiluminescence Immunoassay (CLIA) Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Chemiluminescence Immunoassay (CLIA) Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Chemiluminescence Immunoassay (CLIA) Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Lateral Flow Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Lateral Flow Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Lateral Flow Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Polymerase Chain Reaction (PCR) Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Polymerase Chain Reaction (PCR) Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Polymerase Chain Reaction (PCR) Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Next-Generation Sequencing (NGS) Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Next-Generation Sequencing (NGS) Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Next-Generation Sequencing (NGS) Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Immunoturbidimetry Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Immunoturbidimetry Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Immunoturbidimetry Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global MALDI-TOF Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global MALDI-TOF Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global MALDI-TOF Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Clinical IVD Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 156. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Swab Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Swab Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Swab Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Nasopharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Nasopharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Nasopharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Oropharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Oropharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Oropharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Cerebrospinal Fluid Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Cerebrospinal Fluid Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Cerebrospinal Fluid Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Tissue Biopsy / FFPE Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Tissue Biopsy / FFPE Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Tissue Biopsy / FFPE Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Stool Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Stool Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Stool Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Dried Blood Spots Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Dried Blood Spots Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Dried Blood Spots Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Clinical IVD Reagents Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 193. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Viral Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Viral Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Viral Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Bacterial Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Bacterial Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Bacterial Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Parasitic Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Parasitic Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Parasitic Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global Fungal Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Global Fungal Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. Global Fungal Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 208. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 211. Global Tumor Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Global Tumor Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. Global Tumor Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 214. Global Companion Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 215. Global Companion Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. Global Companion Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 217. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 220. Global Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Global Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. Global Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 223. Global Autoimmune Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 224. Global Autoimmune Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. Global Autoimmune Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 226. Global Endocrinology Market Size, by Region, 2017-2032 (USD Million)
TABLE 227. Global Endocrinology Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. Global Endocrinology Market Size, by Country, 2017-2032 (USD Million)
TABLE 229. Global Renal Function Market Size, by Region, 2017-2032 (USD Million)
TABLE 230. Global Renal Function Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. Global Renal Function Market Size, by Country, 2017-2032 (USD Million)
TABLE 232. Global Hepatic Function Market Size, by Region, 2017-2032 (USD Million)
TABLE 233. Global Hepatic Function Market Size, by Group, 2017-2032 (USD Million)
TABLE 234. Global Hepatic Function Market Size, by Country, 2017-2032 (USD Million)
TABLE 235. Global Prenatal And Neonatal Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 236. Global Prenatal And Neonatal Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 237. Global Prenatal And Neonatal Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 238. Global Transplantation Market Size, by Region, 2017-2032 (USD Million)
TABLE 239. Global Transplantation Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. Global Transplantation Market Size, by Country, 2017-2032 (USD Million)
TABLE 241. Global Toxicology Market Size, by Region, 2017-2032 (USD Million)
TABLE 242. Global Toxicology Market Size, by Group, 2017-2032 (USD Million)
TABLE 243. Global Toxicology Market Size, by Country, 2017-2032 (USD Million)
TABLE 244. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 245. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 246. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 247. Global Clinical IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 249. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 251. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 254. Global Point Of Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 255. Global Point Of Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. Global Point Of Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 257. Global Physician Office Market Size, by Region, 2017-2032 (USD Million)
TABLE 258. Global Physician Office Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. Global Physician Office Market Size, by Country, 2017-2032 (USD Million)
TABLE 260. Global Emergency Department Market Size, by Region, 2017-2032 (USD Million)
TABLE 261. Global Emergency Department Market Size, by Group, 2017-2032 (USD Million)
TABLE 262. Global Emergency Department Market Size, by Country, 2017-2032 (USD Million)
TABLE 263. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 264. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 265. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 266. Global Home Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 267. Global Home Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. Global Home Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 269. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 270. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 272. Global Blood Banks Market Size, by Region, 2017-2032 (USD Million)
TABLE 273. Global Blood Banks Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. Global Blood Banks Market Size, by Country, 2017-2032 (USD Million)
TABLE 275. Global Diagnostic Manufacturers (OEM) Market Size, by Region, 2017-2032 (USD Million)
TABLE 276. Global Diagnostic Manufacturers (OEM) Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. Global Diagnostic Manufacturers (OEM) Market Size, by Country, 2017-2032 (USD Million)
TABLE 278. Global Clinical IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 279. Asia-Pacific Clinical IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 280. Asia-Pacific Clinical IVD Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. Asia-Pacific Clinical IVD Reagents Market Size, by Immunoassay Reagents, 2017-2032 (USD Million)
TABLE 282. Asia-Pacific Clinical IVD Reagents Market Size, by Clinical Chemistry Reagents, 2017-2032 (USD Million)
TABLE 283. Asia-Pacific Clinical IVD Reagents Market Size, by Molecular Diagnostics Reagents, 2017-2032 (USD Million)
TABLE 284. Asia-Pacific Clinical IVD Reagents Market Size, by PCR Reagents, 2017-2032 (USD Million)
TABLE 285. Asia-Pacific Clinical IVD Reagents Market Size, by Next-Generation Sequencing Reagents, 2017-2032 (USD Million)
TABLE 286. Asia-Pacific Clinical IVD Reagents Market Size, by Hematology Reagents, 2017-2032 (USD Million)
TABLE 287. Asia-Pacific Clinical IVD Reagents Market Size, by Coagulation Reagents, 2017-2032 (USD Million)
TABLE 288. Asia-Pacific Clinical IVD Reagents Market Size, by Microbiology Reagents, 2017-2032 (USD Million)
TABLE 289. Asia-Pacific Clinical IVD Reagents Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 290. Asia-Pacific Clinical IVD Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 291. Asia-Pacific Clinical IVD Reagents Market Size, by Swab Samples, 2017-2032 (USD Million)
TABLE 292. Asia-Pacific Clinical IVD Reagents Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 293. Asia-Pacific Clinical IVD Reagents Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 294. Asia-Pacific Clinical IVD Reagents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 295. Asia-Pacific Clinical IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Asia-Pacific Clinical IVD Reagents Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
TABLE 297. North America Clinical IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 298. North America Clinical IVD Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. North America Clinical IVD Reagents Market Size, by Immunoassay Reagents, 2017-2032 (USD Million)
TABLE 300. North America Clinical IVD Reagents Market Size, by Clinical Chemistry Reagents, 2017-2032 (USD Million)
TABLE 301. North America Clinical IVD Reagents Market Size, by Molecular Diagnostics Reagents, 2017-2032 (USD Million)
TABLE 302. North America Clinical IVD Reagents Market Size, by PCR Reagents, 2017-2032 (USD Million)
TABLE 303. North America Clinical IVD Reagents Market Size, by Next-Generation Sequencing Reagents, 2017-2032 (USD Million)
TABLE 304. North America Clinical IVD Reagents Market Size, by Hematology Reagents, 2017-2032 (USD Million)
TABLE 305. North America Clinical IVD Reagents Market Size, by Coagulation Reagents, 2017-2032 (USD Million)
TABLE 306. North America Clinical IVD Reagents Market Size, by Microbiology Reagents, 2017-2032 (USD Million)
TABLE 307. North America Clinical IVD Reagents Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 308. North America Clinical IVD Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 309. North America Clinical IVD Reagents Market Size, by Swab Samples, 2017-2032 (USD Million)
TABLE 310. North America Clinical IVD Reagents Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 311. North America Clinical IVD Reagents Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 312. North America Clinical IVD Reagents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 313. North America Clinical IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. North America Clinical IVD Reagents Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
TABLE 315. Latin America Clinical IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 316. Latin America Clinical IVD Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 317. Latin America Clinical IVD Reagents Market Size, by Immunoassay Reagents, 2017-2032 (USD Million)
TABLE 318. Latin America Clinical IVD Reagents Market Size, by Clinical Chemistry Reagents, 2017-2032 (USD Million)
TABLE 319. Latin America Clinical IVD Reagents Market Size, by Molecular Diagnostics Reagents, 2017-2032 (USD Million)
TABLE 320. Latin America Clinical IVD Reagents Market Size, by PCR Reagents, 2017-2032 (USD Million)
TABLE 321. Latin America Clinical IVD Reagents Market Size, by Next-Generation Sequencing Reagents, 2017-2032 (USD Million)
TABLE 322. Latin America Clinical IVD Reagents Market Size, by Hematology Reagents, 2017-2032 (USD Million)
TABLE 323. Latin America Clinical IVD Reagents Market Size, by Coagulation Reagents, 2017-2032 (USD Million)
TABLE 324. Latin America Clinical IVD Reagents Market Size, by Microbiology Reagents, 2017-2032 (USD Million)
TABLE 325. Latin America Clinical IVD Reagents Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 326. Latin America Clinical IVD Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 327. Latin America Clinical IVD Reagents Market Size, by Swab Samples, 2017-2032 (USD Million)
TABLE 328. Latin America Clinical IVD Reagents Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 329. Latin America Clinical IVD Reagents Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 330. Latin America Clinical IVD Reagents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 331. Latin America Clinical IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 332. Latin America Clinical IVD Reagents Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
TABLE 333. Europe Clinical IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 334. Europe Clinical IVD Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 335. Europe Clinical IVD Reagents Market Size, by Immunoassay Reagents, 2017-2032 (USD Million)
TABLE 336. Europe Clinical IVD Reagents Market Size, by Clinical Chemistry Reagents, 2017-2032 (USD Million)
TABLE 337. Europe Clinical IVD Reagents Market Size, by Molecular Diagnostics Reagents, 2017-2032 (USD Million)
TABLE 338. Europe Clinical IVD Reagents Market Size, by PCR Reagents, 2017-2032 (USD Million)
TABLE 339. Europe Clinical IVD Reagents Market Size, by Next-Generation Sequencing Reagents, 2017-2032 (USD Million)
TABLE 340. Europe Clinical IVD Reagents Market Size, by Hematology Reagents, 2017-2032 (USD Million)
TABLE 341. Europe Clinical IVD Reagents Market Size, by Coagulation Reagents, 2017-2032 (USD Million)
TABLE 342. Europe Clinical IVD Reagents Market Size, by Microbiology Reagents, 2017-2032 (USD Million)
TABLE 343. Europe Clinical IVD Reagents Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 344. Europe Clinical IVD Reagents Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 345. Europe Clinical IVD Reagents Market Size, by Swab Samples, 2017-2032 (USD Million)
TABLE 346. Europe Clinical IVD Reagents Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 347. Europe Clinical IVD Reagents Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 348. Europe Clinical IVD Reagents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 349. Europe Clinical IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 350. Europe Clinical IVD Reagents Market Size, by Point Of Care Settings, 2017-2032 (USD Million)
TABLE 351. Middle East Clinical IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 352. Middle East Clinical IVD Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 353. Middle East Clinical IVD Reagents Market Size, by Immunoassay Reagents, 2017-2032 (USD Million)
TABLE 354. Middle East Clinical IVD Reagents Market Size, by Clinical Chemistry Reagents, 2017-2032 (USD Million)
TABLE 355. Middle East Clinical IVD Reagents Market Size, by Molecular Diagnostics Reagents, 2017-2032 (USD Million)
TABLE 356. Middle East Clinical IVD Reagents Market Size, by PCR Reagents, 2017-2032 (USD Million)
TABLE 357. Middle East Clinical IVD Reagents Market Size, by Next-Generation Sequencing Reagents, 2017-2032 (USD Million)
TABLE 358. Middle East Clinical IVD Reagents Market Size, by Hematology Reagents, 2017-2032 (USD Million)
TABLE 359. Middle East Clinical IVD Reagents Market Size, by

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • ARKRAY, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Cepheid AB
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • Hologic, Inc.
  • Illumina, Inc.
  • InTec Products, Inc.
  • Luminex Corporation
  • Merck KGaA
  • Mindray Medical International Limited
  • OraSure Technologies, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation

Related Topics

Related Reports

IVD Reagents Market - Global Forecast 2026-2032 - Product Image

IVD Reagents Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
IVD Reagents Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Technology - Product Image

IVD Reagents Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Technology

  • Report
  • 160 Pages
  • Global
From
Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032 - Product Image

Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
South Africa IVD Centralized Diagnostics Market (By Segment - Immunoassay, Clinical Chemistry, Coagulation, Hematology, Urinalysis, Rest of Centralized Diagnostics), Company Share Analysis, Market Dynamics and Recent Developments - Forecast to 2032 - Product Image

South Africa IVD Centralized Diagnostics Market (By Segment - Immunoassay, Clinical Chemistry, Coagulation, Hematology, Urinalysis, Rest of Centralized Diagnostics), Company Share Analysis, Market Dynamics and Recent Developments - Forecast to 2032

  • Report
  • 115 Pages
  • South Africa
From
IVD Contract Manufacturing - Global Strategic Business Report - Product Image

IVD Contract Manufacturing - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.